Compare RVLV & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RVLV | PLSE |
|---|---|---|
| Founded | 2003 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.5B |
| IPO Year | 2018 | 2015 |
| Metric | RVLV | PLSE |
|---|---|---|
| Price | $20.34 | $18.65 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 1 |
| Target Price | ★ $29.73 | $22.00 |
| AVG Volume (30 Days) | ★ 844.2K | 224.7K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 24.64 | N/A |
| EPS | ★ 0.20 | N/A |
| Revenue | ★ $1,225,682,000.00 | N/A |
| Revenue This Year | $10.96 | $840.00 |
| Revenue Next Year | $8.01 | $287.54 |
| P/E Ratio | $27.44 | ★ N/A |
| Revenue Growth | ★ 8.48 | N/A |
| 52 Week Low | $17.01 | $12.56 |
| 52 Week High | $31.68 | $26.30 |
| Indicator | RVLV | PLSE |
|---|---|---|
| Relative Strength Index (RSI) | 27.08 | 41.83 |
| Support Level | $18.08 | $17.32 |
| Resistance Level | $22.52 | $20.40 |
| Average True Range (ATR) | 1.19 | 1.42 |
| MACD | -0.61 | -0.44 |
| Stochastic Oscillator | 8.99 | 14.35 |
Revolve Group Inc is an emerging e-commerce retailer, selling women's dresses, handbags, shoes, beauty products, and incidentals across its marketplace properties, Revolve and FWRD. The platform is built to suit the "next-generation customer," emphasizing mobile commerce, influencer marketing, and occupying an aspirational but attainable luxury niche. With $1.1 billion in 2024 net sales, the firm sits just outside the top 30 apparel retailers (by sales) in the U.S, but has consistently generated robust top-line growth as the industry continues to favor digital channels. Revolve generates approximately 18% of sales from private-label offerings, while focusing on building an inventory of distinctive products from emerging fashion brands with less than $10 million in annual sales.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.